Endogenous Peptides in Circulatory Shock

  • Winfried Krause
  • Karen Nieber
  • Peter Oehme
Chapter
Part of the Biochemical Endocrinology book series (BIOEND)

Abstract

Circulatory shock may be considered as a special and severe form of stress. It is a complex syndrome and is characterized by a severely disturbed hemostasis of the entire organism.

Keywords

Opioid Receptor Hemorrhagic Shock Adrenal Medulla Shock State Endotoxic Shock 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in to check access.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Bhargava, H. N., Walter, R., and Ritzmann, R. F., 1980, Development of narcotic tolerance and physical dependence. Effects of Pro-Leu-Gly-NH2 and cyclo (Leu-Gly), Pharmacol. Biochem. Behav. 12:73.PubMedCrossRefGoogle Scholar
  2. Bhargava, H. N., 1980a, Cyclo(Leucylglycine) inhibits the development of morphine-induced analgesic tolerance and dopamine receptor supersensitivity in rats, Life Sci. 27:117.CrossRefGoogle Scholar
  3. Bhargava, H. N., and Kim, H. S., 1982, Structure activity relationship studies with hypothalamic peptide hormones. I. Effect of melanotropin release-inhibiting factor and analogs on tolerance to morphine in the rat, J. Pharmacol. Exp. Therap. 220:394.Google Scholar
  4. Bond, R. F., Manley jr. E. S., and Green, H. D., 1967, Cutaneous and sceletal muscle vascular responses to hemorrhage and irreversible shock, Amer. J. Physiol. 212:488.PubMedGoogle Scholar
  5. Celis, M. E., 1980, Effects of different opiate agonists on melanocyte-stimulating hormone release: In vivo and in vitro studies, Can. J. Physiol. Pharmacol. 58:326.PubMedCrossRefGoogle Scholar
  6. Chien, S., 1967, Role of the sympathetic nervous system in hemorrhage, Physiol. Rev. 47:214.PubMedGoogle Scholar
  7. Chiu, S., Wong, Y.-W., Ferris, J. A., Johnson, R., and Mishra, R. K., 1983, Binding studies of L-prolyl-L-leucyl-glycinamide (PLG), a novel antiparkinsonian agent, in normal brain, Pharmacol. Res. Commun. 15:41.PubMedCrossRefGoogle Scholar
  8. Czionkowiski, A., Hollt, V., and Herz, A., 1978, Binding of opiate and endogenous opioid peptides to neuro-leptic receptor sites. Life Sci. 22:953.CrossRefGoogle Scholar
  9. Faden, A. I., and Holaday, J. W., 1979, Opiate anta-gonists: A role in the treatment of hypovolemic shock, Science 205:317.PubMedCrossRefGoogle Scholar
  10. Görne, R. C., Pfister, C., Rathsack, R., and Oehme, P., 1984, Zur zellulären Verteilung von Substanz P im Nebennierenmark der Ratte, Biomed. Biochim. Acta 43:135.PubMedGoogle Scholar
  11. Hecht, K., Oehme, P., Kolometsewa, I. A., Ljowschina, I. P., Poppei, M., and Airapetjanz, M. G., 1980, Effect of substance P analogue on chronic deprivation of sleep of wistar rats under stress, in: "Neuropeptides and Neural Transmission", C. A. Marsan and W. Z. Traczyk, eds., IBRO Series, Vol. 7, Raven Press, New York, p. 159.Google Scholar
  12. Holaday, J. W., and Faden, A. I., 1978, Naloxone reversal of endotoxin hypotension suggests role of endorphins in shock, Nature (London) 275:450.CrossRefGoogle Scholar
  13. Holaday, J. W., Tseng, L. H., Loh, H. H., and Li, C. H., 1978a, Thyrotropin-releasing hormone antagonizes ß-endorphin hypothermia and catalepsy, Life Sci. 22:1537.CrossRefGoogle Scholar
  14. Holaday, J. W., D’Amato, R. J., and Faden, A. I., 1981, Thyrotropin-releasing hormone improves cardio-vascular function in experimental endotoxic and hemorrhagic shock, Science 213:216.PubMedCrossRefGoogle Scholar
  15. Holaday, J. W., Ruvio, L. E., Johnson, C. E., and D’Amato, R. J., 1982, M 154.129, a putative d-antagonist, reverses endotoxic shock without altering morphine analgesia, Life Sci. 31:2359.PubMedCrossRefGoogle Scholar
  16. Holaday, J. W., Pasternak, G. W., D’Amato, R. J., Ruvio, B. A., and Faden, A. I., 1983, Naloxazone lacks therapeutic effects in endotoxic shock yet blocks the effects of naloxone, Europ. J. Pharmacol. 89:293.CrossRefGoogle Scholar
  17. Holaday, J. W., 1983a, Cardiovascular effects of endo-genous opiate systems, Ann. Rev. Pharmacol. Toxicol. 23:541.CrossRefGoogle Scholar
  18. Holaday, J. W., D’Amato, R. J., Ruvio, B. A., Feuer-stein, G., and Faden, A. I., 1983b, Adrenalectomy blocks pressor responses to naloxone in endotoxic shock: Evidence for sympathomedullary involvement, Circ. Shock 11:201.PubMedGoogle Scholar
  19. Horita, A., Carino, M. A., and Chestnut, R. M., 1976, Influence of thyrotropin-releasing hormone (TRH) on drug induced narcosis and hypothermia in rabbits, Psychopharmacol. 49:57.Google Scholar
  20. Kostrezewa, R. M, Kastin, A. J., and Sobrian, S. K., 1978, Potentiation of apomorphine action in rats by l-prolyl-l-leucyl-glycine-amide, Pharmacol.Biochem. Behav. 9:375.CrossRefGoogle Scholar
  21. Kovách, A. G. B., Rosell, S., Koltay, E., Sandor, P., Szabo, L., Ligeti, L., and Urbanics, R., 1977, Cardiovascular effects of substance P during hemorrhagic shock and hypotension, in: "Substance P", U. S. von Euler and B. Pernow, eds., Raven Press, New York, p. 321.Google Scholar
  22. Lewis, J. W., Tordoff, M. G., Sherman, J. E., and Liebeskind, J. C., 1982, Adrenal medullary enke-phaline-like peptides may mediate opioid stress analgesia, Science 217:557.PubMedCrossRefGoogle Scholar
  23. Livett, B. G., Kozousek, V., Mizobe, F., and Dean, D. M., 1979, Substance P inhibits nicotinic activation of chromaffin cells, Nature (London) 278:256.CrossRefGoogle Scholar
  24. Oehme, P., Hecht, K., Piesche, L., Hilse, H., Morgenstern, E., Poppei, M., 1980, Substance P as a modulator of physiological and pathological processes, in: "Neuropeptides and Neural Transmission", C. A. Marsan and W. Z. Traczyk, eds., IBRO Series, Vol. 7, Raven Press, New York, p. 73.Google Scholar
  25. Mann, M. B., Whitney, D. R., 1947, On a test of whether one of two random variables is stochastically larger than the other, Ann, Math. Statist, 18:50.CrossRefGoogle Scholar
  26. Nieber, K., and Oehme, P., 1981, "Gut dependence" auf Opiate bei Ratten mit spontaner Hypertonie, Pharmazie 36:515.PubMedGoogle Scholar
  27. Patton, M. L., Gurll, N. J., Reynolds, D. G., Vargish, T., and Ganes, E. M., 1982, Adrenalectomy abolishes the naloxone effect in hemorrhagic shock, Circ.Shock 9:173.Google Scholar
  28. Plottnikoff, N. P., Kastin, A. J., Anderson, M. S., and Schally, A. V., 1971, Dopa potentiation by a hypothalamic factor MSH release-inhibiting hormone (MIF), Life Sci. 10:1279.CrossRefGoogle Scholar
  29. Rathsack, R., Oehme, P., Roske, I., and Hilse, H., 1983, Substance P-like immunoreactivity in plasma and adrenal medulla of rats with spontaneous hypertension and WKY rats under acute stress, Biomed. Biochim. Acta 42:955.PubMedGoogle Scholar
  30. Roske, I., Rathsack, R., Hilse, H., and Oehme, P., 1983, Verhalten von Blutdruck und "Substance P-like immunoreactivity" (SPLIR) im Plasma von Ratten mit genetisch fixierter Hypertonie (SHR) unter chronisch intermittierender Immobilisation, Biomed. Biochim.Acta 42:731.PubMedGoogle Scholar
  31. Rutherford, R. B., Kaihara, S., Schwentker, E. P., and Wagner jr., H. N., 1968, Regional blood flow in hemorrhagic shock by the distribution of labelled mocrospheres, Surg. Forum 19:14.PubMedGoogle Scholar
  32. Tache, Y., Lis, M., and Collu, R., 1977, Effects of thyrotropin-releasing hormone on behavioral and hormonal changes induced by ß-endorphin, Life Sci.21:841.PubMedCrossRefGoogle Scholar
  33. Van Loom, G. R., Appel, N. M., and Ho, D., 1981, ß-Endorphin-induced stimulation of central sympathetic outflow: ß-Endorphin increases plasma concentrations of epinephrine, norepinephrine and dopamine in rats. Endocrinology 109:46.CrossRefGoogle Scholar

Copyright information

© Plenum Press, New York 1985

Authors and Affiliations

  • Winfried Krause
    • 1
  • Karen Nieber
    • 1
  • Peter Oehme
    • 1
  1. 1.Institute of Drug ResearchAcademy of Sciences of the GDRBerlin-FriedrichsfeldeGermany

Personalised recommendations